Search research articles
Contact Us
Filters
Showing results (41-50 of 70) with videos related to
Page
of 7
Sort By:
Psychology Research and Behavior Management
|
December 24, 2021
A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing "Precision Behavioral Management"
Kenneth Blum, Bruce Steinberg, Marjorie C Gondre-Lewis, et al.
Annals of Neurology
|
September 27, 2014
Short-term risk of stroke after dizziness presentation. Reply
Kevin A Kerber, Darin B Zahuranec, Devin L Brown, et al.
Journal of Systems and Integrative Neuroscience
|
September 11, 2018
"Dopamine homeostasis" requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America's drug epidemic
Kenneth Blum, Edward J Modestino, Marjorie Gondré-Lewis, et al.
Acta Scientific Neurology
|
March 8, 2021
Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality?
Kenneth Blum, Ali Raza, Tiffany Schultz, et al.
Current Psychopharmacology
|
September 1, 2021
Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) <i>via</i> Activation of Neuro-immunological Function in the Face of a Viral Pandemic
Kenneth Blum, Edward J Modestino, David Baron, et al.
Journal of Behavioral Addictions
|
July 14, 2015
Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette's syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic amino-acid therapy (NAAT)
Thomas Mclaughlin, Marlene Oscar-Berman, Thomas Simpatico, et al.
Journal of Personalized Medicine
|
December 29, 2022
Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family
Catherine A Dennen, Kenneth Blum, Abdalla Bowirrat, et al.
Journal of Reward Deficiency Syndrome and Addiction Science
|
July 3, 2018
Hypothesizing Las Vegas and Sutherland Springs Mass Shooters Suffer from Reward Deficiency Syndrome: "Born Bad"
Thomas McLaughlin, Kenneth Blum, Bruce Steinberg, et al.
Journal of Personalized Medicine
|
April 3, 2021
A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration
Kenneth Blum, Shan Kazmi, Edward J Modestino, et al.
Current Psychopharmacology
|
May 21, 2020
In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing
Kenneth Blum, David Baron, Lisa Lott, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 70) with videos related to
Sort By:
Page
of 7
Psychology Research and Behavior Management
|
December 24, 2021
A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing "Precision Behavioral Management"
Kenneth Blum, Bruce Steinberg, Marjorie C Gondre-Lewis, et al.
Annals of Neurology
|
September 27, 2014
Short-term risk of stroke after dizziness presentation. Reply
Kevin A Kerber, Darin B Zahuranec, Devin L Brown, et al.
Journal of Systems and Integrative Neuroscience
|
September 11, 2018
"Dopamine homeostasis" requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America's drug epidemic
Kenneth Blum, Edward J Modestino, Marjorie Gondré-Lewis, et al.
Acta Scientific Neurology
|
March 8, 2021
Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality?
Kenneth Blum, Ali Raza, Tiffany Schultz, et al.
Current Psychopharmacology
|
September 1, 2021
Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) <i>via</i> Activation of Neuro-immunological Function in the Face of a Viral Pandemic
Kenneth Blum, Edward J Modestino, David Baron, et al.
Journal of Behavioral Addictions
|
July 14, 2015
Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette's syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic amino-acid therapy (NAAT)
Thomas Mclaughlin, Marlene Oscar-Berman, Thomas Simpatico, et al.
Journal of Personalized Medicine
|
December 29, 2022
Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family
Catherine A Dennen, Kenneth Blum, Abdalla Bowirrat, et al.
Journal of Reward Deficiency Syndrome and Addiction Science
|
July 3, 2018
Hypothesizing Las Vegas and Sutherland Springs Mass Shooters Suffer from Reward Deficiency Syndrome: "Born Bad"
Thomas McLaughlin, Kenneth Blum, Bruce Steinberg, et al.
Journal of Personalized Medicine
|
April 3, 2021
A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration
Kenneth Blum, Shan Kazmi, Edward J Modestino, et al.
Current Psychopharmacology
|
May 21, 2020
In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing
Kenneth Blum, David Baron, Lisa Lott, et al.
Page
of 7